Edwards Lifesciences Corp/ US28176E1082 /
04/09/2024 21:59:57 | Chg. +0.18 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
68.92USD | +0.26% | 155,524 Turnover: 10.75 mill. |
-Bid Size: - | -Ask Size: - | 41.52 bill.USD | - | 29.84 |
Assets
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | 373.3000 | 421.6000 | 442.9000 | 482.5000 | 580 | ||||||
Intangible Assets | 67 | 57.2000 | 23.4000 | 205.4000 | 204.8000 | ||||||
Long-Term Investments | - | - | 240.9000 | 379.9000 | 532.1000 | ||||||
Fixed Assets | - | - | 1,229.7000 | 2,011.4000 | 2,270 | ||||||
Inventories | 281 | 308.9000 | 296.8000 | 339.9000 | 396.6000 | ||||||
Accounts Receivable | 321.1000 | 302.5000 | 288 | 315.4000 | 365.5000 | ||||||
Cash and Cash Equivalents | 310.9000 | 420.4000 | 653.8000 | 718.4000 | 930.1000 | ||||||
Current Assets | 1,291.9000 | 1,725.8000 | 2,294.6000 | 2,047.9000 | 2,240 | ||||||
Total Assets | 2,221.5000 | 2,724.7000 | 3,524.3000 | 4,059.3000 | 4,510 |
Liabilities
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | 74.7000 | 48.4000 | 58.2000 | 63.9000 | 97.1000 | ||||||
Long-term debt | - | - | 598.1000 | 599.9000 | 822.3000 | ||||||
Liabilities to Banks | - | - | - | - | - | ||||||
Provisions | 263.2000 | 297.2000 | 376.2000 | 412.3000 | 435.4000 | ||||||
Liabilities | 742.2000 | 1,165.5000 | 1,332.9000 | 1,556.2000 | 1,891 | ||||||
Share Capital | - | - | 257.8000 | 717.3000 | 727.8000 | ||||||
Total Equity | 1,479.3000 | 1,559.2000 | 2,191.4000 | 2,503.1000 | 2,619 | ||||||
Minority Interests | - | - | - | - | - | ||||||
Total liabilities equity | 2,221.5000 | 2,724.7000 | 3,524.3000 | 4,059.3000 | 4,510 |
Income Statement
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 1,899.6000 | 2,045.5000 | 2,322.9000 | 2,493.7000 | 2,963.7000 | ||||||
Depreciation (total) | - | - | 68.6000 | 65.8000 | - | ||||||
Operating Result | 392.4000 | 521.8000 | - | - | - | ||||||
Interest Income | .4000 | -5.2000 | 10.8000 | 9.3000 | 8.4000 | ||||||
Income Before Taxes | 391.1000 | 515.3000 | 1,144 | 622.4000 | 737.9000 | ||||||
Income Taxes | 97.9000 | 123.6000 | 332.9000 | 127.5000 | 168.4000 | ||||||
Minority Interests Profit | - | - | - | - | - | ||||||
Net Income | 293.2000 | 391.7000 | 811.1000 | 494.9000 | 569.5000 |
Per Share
Cash Flow
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | 373.8000 | 472.7000 | 1,022.3000 | 549.7000 | 704.4000 | ||||||
Cash Flow from Investing Activities | -90.5000 | -412.7000 | -633 | -316.1000 | -211.7000 | ||||||
Cash Flow from Financing | -155.6000 | 34.9000 | -153 | -158.6000 | -268.5000 | ||||||
Decrease / Increase in Cash | 139.7000 | 109.5000 | 233.4000 | 64.6000 | 211.7000 | ||||||
Employees | 8,200 | 8,600 | 9,100 | 9,800 | 11,100 |